PALO ALTO, Calif.– HP (NYSE:HPQ) today announced it is collaborating with Systems Biology Ireland (SBI) on life sciences research aimed at providing a powerful new way to use the strength of computers and mathematics to understand biology.

The SBI research program, enabled by HP scale-out storage technology, seeks to unravel the complexities of cells through the use of models that predict biological behavior.

Modern life sciences research is data intensive, generating considerable amounts of information that needs to be stored, managed and retrieved in an instant. SBI is using the multipetabyte storage capacity of the HP StorageWorks 9100 Extreme Data Storage (ExDS9100) system to improve the efficiency of research processes.

“The research being undertaken by SBI will aid the development of new treatments for medical conditions, including various cancers, and allow for better therapies to be delivered faster and more effectively to patients,” said David Medina, executive lead, Worldwide Life Sciences and Pharma Segment, HP. “The HP ExDS9100 helps make the SBI program possible by driving efficiency in research and dramatically reducing the complexity and cost of storage.”

The HP ExDS9100 allows customers to easily manage large amounts of data, save datacenter space and lower costs. For customers needing high levels of scalability, such as SBI, the ExDS9100 can hold up to 16 BladeSystem c-Class server blades with hundreds of terabytes of storage capacity. To save administrative time, the ExDS9100 features a single management interface that allows complete visibility to the performance utilization and capacity of servers and storage within the system.

“The next phase of discoveries in biomedical research will be at the nexus of technology, computation, chemistry, modeling and biology,” said Professor Walter Kolch, director, Systems Biology Ireland, University College Dublin. “Extending beyond our storage needs, our collaboration with HP includes engaging knowledgeable people who understand our business and this complex industry. By working with HP and other organizations around the world, we can help speed up the experimentation process and reduce the number of years it takes to develop a new drug therapy.”

The SBI research program is a collaboration among industry and academic organizations, including Agilent Technologies, Ark Therapeutics, HP, Protagen AG, Science Foundation Ireland, Servier, Siemens Ireland and University College Dublin.

About HP

HP, the world’s largest technology company, simplifies the technology experience for consumers and businesses with a portfolio that spans printing, personal computing, software, services and IT infrastructure. More information about HP is available at https://www.hp.com/.

Note to editors: More news from HP, including links to RSS feeds, is available at https://www.hp.com/hpinfo/newsroom/.

This news release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of HP and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to statements of the plans, strategies and objectives of management for future operations; any statements concerning expected development, performance or market share relating to products and services; any statements regarding anticipated operational and financial results; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. Risks, uncertainties and assumptions include macroeconomic and geopolitical trends and events; the execution and performance of contracts by HP and its customers, suppliers and partners; the achievement of expected operational and financial results; and other risks that are described in HP’s Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2009 and HP’s other filings with the Securities and Exchange Commission, including but not limited to HP’s Annual Report on Form 10-K for the fiscal year ended October 31, 2008. HP assumes no obligation and does not intend to update these forward-looking statements.

© 2009 Hewlett-Packard Development Company, L.P. The information contained herein is subject to change without notice. The only warranties for HP products and services are set forth in the express warranty statements accompanying such products and services. Nothing herein should be construed as constituting an additional warranty. HP shall not be liable for technical or editorial errors or omissions contained herein.